Total raised
—
Last: 2025-07
Stage
Pre-Seed
Founded
2024
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Diastole Medical develops AI-driven software that analyzes Doppler ultrasound signals from existing echocardiography systems to support non-invasive coronary diagnostics. The platform is designed for healthcare providers evaluating coronary artery disease and coronary microvascular dysfunction, helping clinicians visualize coronary flow dynamics, generate point-of-care insights, and reduce reliance on unnecessary invasive angiography.
Funding history · 1 round · — total
2025-07
Undisclosed Round
Undisclosed
Q&A
- What is Diastole Medical's primary focus?
- Diastole Medical develops AI-driven software that analyzes Doppler ultrasound signals from existing echocardiography systems to support non-invasive coronary diagnostics.
- When was Diastole Medical founded?
- Diastole Medical was founded in October 2024.
- Where is Diastole Medical headquartered?
- Diastole Medical is headquartered in Tel Aviv-Yafo, Israel.
- What is Diastole Medical's current employee count?
- Diastole Medical has 5 employees, falling within the 1-10 employee bucket.
- What is the primary sector for Diastole Medical?
- Diastole Medical's primary sector is Health Tech & Life Sciences.
- What is the current product stage of Diastole Medical?
- Diastole Medical's product is currently in the R&D stage.
- What business model does Diastole Medical primarily use?
- Diastole Medical primarily uses a B2B business model.
- What is Diastole Medical's current funding stage?
- Diastole Medical is currently in the Pre-Seed funding stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical WorkflowDigital Medical Diagnostics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatients
Business model
B2B
Highlights
Verified
Tags
diagnosticsheart-failureheart-diseasesultrasound